NCT02517684View on ClinicalTrials.gov

Top-down Infliximab Study in Kids With Crohn's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

December 31, 2019

Study Completion Date

January 31, 2024

Conditions
Crohn's Disease
Interventions
DRUG

Infliximab

DRUG

Prednisolone

OTHER

Exclusive enteral nutrition

DRUG

Azathioprine

Trial Locations (13)

Unknown

University Hospital Brussels, Brussels

University Hospitals Leuven, Leuven

Helsinki University Central Hospital, Helsinki

Academic Medical Center, Amsterdam

VU University Medical Center, Amsterdam

Amphia Hospital, Breda

Medisch Spectrum Twente, Enschede

Leiden University Medical Center, Leiden

Radboud University Medical Center, Nijmegen

Maasstad Hospital, Rotterdam

University Medical Center Utrecht, Utrecht

Isala hospital, Zwolle

3000 CA

Erasmus Medical Center, Rotterdam

Sponsors
All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

collaborator

Hospira, now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

Erasmus Medical Center

OTHER